Research output: Contribution to journal › Article › peer-review
Minor changes in erythrocyte osmotic fragility in trace amine-associated receptor 5 (Taar5) knockout mice. / Zhukov, Ilya S.; Kubarskaya, Larisa G.; Karpova, Inessa V.; Vaganova, Anastasia N.; Karpenko, Marina N.; Gainetdinov, Raul R.
In: International Journal of Molecular Sciences, Vol. 22, No. 14, 7307, 07.07.2021.Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Minor changes in erythrocyte osmotic fragility in trace amine-associated receptor 5 (Taar5) knockout mice
AU - Zhukov, Ilya S.
AU - Kubarskaya, Larisa G.
AU - Karpova, Inessa V.
AU - Vaganova, Anastasia N.
AU - Karpenko, Marina N.
AU - Gainetdinov, Raul R.
N1 - Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. Copyright: Copyright 2021 Elsevier B.V., All rights reserved.
PY - 2021/7/7
Y1 - 2021/7/7
N2 - Trace amine-associated receptors (TAARs) are a group of G protein-coupled receptors that are expressed in the olfactory epithelium, central nervous system, and periphery. TAAR family generally consists of nine types of receptors (TAAR1-9), which can detect biogenic amines. During the last 5 years, the TAAR5 receptor became one of the most intriguing receptors in this subfamily. Recent studies revealed that TAAR5 is involved not only in sensing socially relevant odors but also in the regulation of dopamine and serotonin transmission, emotional regulation, and adult neurogenesis by providing significant input from the olfactory system to the limbic brain areas. Such results indicate that future antagonistic TAAR5-based therapies may have high pharmacological potential in the field of neuropsychiatric disorders. TAAR5 is known to be expressed in leucocytes as well. To evaluate potential hematological side effects of such future treatments we analyzed several hematological parameters in mice lacking TAAR5. In these mutants, we observed minor but significant changes in the osmotic fragility test of erythrocytes and hematocrit levels. At the same time, analysis of other parameters including complete blood count and reticulocyte levels showed no significant alterations in TAAR5 knockout mice. Thus, TAAR5 gene knockout leads to minor negative changes in the erythropoiesis or eryptosis processes, and further research in that field is needed. The impact of TAAR5 deficiency on other hematological parameters seems minimal. Such negative, albeit minor, effects of TAAR5 deficiency should be taken into account during future TAAR5-based therapy development.
AB - Trace amine-associated receptors (TAARs) are a group of G protein-coupled receptors that are expressed in the olfactory epithelium, central nervous system, and periphery. TAAR family generally consists of nine types of receptors (TAAR1-9), which can detect biogenic amines. During the last 5 years, the TAAR5 receptor became one of the most intriguing receptors in this subfamily. Recent studies revealed that TAAR5 is involved not only in sensing socially relevant odors but also in the regulation of dopamine and serotonin transmission, emotional regulation, and adult neurogenesis by providing significant input from the olfactory system to the limbic brain areas. Such results indicate that future antagonistic TAAR5-based therapies may have high pharmacological potential in the field of neuropsychiatric disorders. TAAR5 is known to be expressed in leucocytes as well. To evaluate potential hematological side effects of such future treatments we analyzed several hematological parameters in mice lacking TAAR5. In these mutants, we observed minor but significant changes in the osmotic fragility test of erythrocytes and hematocrit levels. At the same time, analysis of other parameters including complete blood count and reticulocyte levels showed no significant alterations in TAAR5 knockout mice. Thus, TAAR5 gene knockout leads to minor negative changes in the erythropoiesis or eryptosis processes, and further research in that field is needed. The impact of TAAR5 deficiency on other hematological parameters seems minimal. Such negative, albeit minor, effects of TAAR5 deficiency should be taken into account during future TAAR5-based therapy development.
KW - Animal knockout model
KW - Erythrocyte fragility
KW - GPCR
KW - Hematology
KW - TAAR
KW - TAAR5
KW - Trace amine-associated receptor
KW - Trace amines
KW - Animal knockout model
KW - Erythrocyte fragility
KW - GPCR
KW - Hematology
KW - TAAR
KW - TAAR5
KW - Trace amine-associated receptor
KW - Trace amines
KW - MECHANISMS
KW - trace amines
KW - hematology
KW - animal knockout model
KW - trace amine-associated receptor
KW - erythrocyte fragility
KW - CELL
UR - http://www.scopus.com/inward/record.url?scp=85109072871&partnerID=8YFLogxK
U2 - 10.3390/ijms22147307
DO - 10.3390/ijms22147307
M3 - Article
AN - SCOPUS:85109072871
VL - 22
JO - International Journal of Molecular Sciences
JF - International Journal of Molecular Sciences
SN - 1422-0067
IS - 14
M1 - 7307
ER -
ID: 78836147